Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iridium Catalyzed Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103288829A details an iridium-catalyzed asymmetric hydrogenation route for chiral dihydro-5H-pyrrolo[2,1-c][1,4]-benzodiazepino-5-one, offering high enantioselectivity and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN102040625B discloses efficient chiral spiro ligands for iridium-catalyzed asymmetric hydrogenation, offering high enantioselectivity and low catalyst loading for pharmaceutical manufacturing.
Patent CN108101785A reveals iridium catalysis for chiral beta-hydroxy esters. Offers high ee and mild conditions for pharma supply chains. Enables cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106995413A reveals high-ee iridium-catalyzed hydrogenation for chiral piperazines, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Novel one-step iridium-catalyzed method for fluorine-containing secondary amines using stable fluorinated alcohols, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN110002952A reveals iridium-catalyzed transfer hydrogenation for high-purity alcohol synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Discover advanced ferrocene-based PNN ligands from patent CN114644663A for high-efficiency ketone hydrogenation, offering reliable supply and cost-effective pharma intermediate manufacturing.